戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 and a pathological reduction in red pulp and extramedullary hematopoiesis.
2  showed transient bone marrow depression and extramedullary hematopoiesis.
3 enitor cells in the bone marrow, and splenic extramedullary hematopoiesis.
4 R/Hedgehog-related genes in spleen, reducing extramedullary hematopoiesis.
5 rythroid differentiation and greatly reduced extramedullary hematopoiesis.
6 a dramatic increase in HSPC mobilization and extramedullary hematopoiesis.
7 a, they have macrocytic anemia and increased extramedullary hematopoiesis.
8 chitecture, bone marrow hypocellularity, and extramedullary hematopoiesis.
9 d splenomegaly with altered architecture and extramedullary hematopoiesis.
10 cture, and infected mice exhibited extensive extramedullary hematopoiesis.
11 at was accompanied by splenomegaly caused by extramedullary hematopoiesis.
12 mph nodes were enlarged and exhibited marked extramedullary hematopoiesis.
13  fibrosis, osteosclerosis, angiogenesis, and extramedullary hematopoiesis.
14 with a recovery of medullary and decrease in extramedullary hematopoiesis.
15 ive hematopoiesis, bone marrow fibrosis, and extramedullary hematopoiesis.
16 nto RBCs via formation of blood islands with extramedullary hematopoiesis.
17 Cs in the spleen, where we observed enhanced extramedullary hematopoiesis.
18 tes, varying degrees of marrow fibrosis, and extramedullary hematopoiesis.
19  defect correlated with disease duration and extramedullary hematopoiesis.
20 rial infection, resulting in a transition to extramedullary hematopoiesis.
21 ls for growing in LEC-1 domains during liver extramedullary hematopoiesis.
22 hetic nervous system, expanded medullary and extramedullary hematopoiesis.
23 e blood cells, bone marrow hypercellularity, extramedullary hematopoiesis, a tendency for thrombosis,
24 , an increase in splenic megakaryocytes, and extramedullary hematopoiesis accompany the hematologic c
25 e capacity is sustained by expanded sites of extramedullary hematopoiesis and is accompanied by multi
26             Mechanistically, FTY720 enhanced extramedullary hematopoiesis and massive accumulation of
27 thalassemia, with the potential of reversing extramedullary hematopoiesis and preventing splenectomy.
28 K hyperplasia, myelofibrosis, and consequent extramedullary hematopoiesis and splenomegaly.
29 2 heterozygous mutant mice exhibit increased extramedullary hematopoiesis and susceptibility to lymph
30 f Hmga2 enhanced megakaryopoiesis, increased extramedullary hematopoiesis, and accelerated the develo
31 enlargement of the spleen, increased splenic extramedullary hematopoiesis, and altered clinicopatholo
32 mune manifestations, including splenomegaly, extramedullary hematopoiesis, and autoantibody productio
33 loproliferation, ineffective erythropoiesis, extramedullary hematopoiesis, and bone marrow fibrosis a
34 acterized by erythrocytosis, granulocytosis, extramedullary hematopoiesis, and bone marrow fibrosis,
35 1(+) granulocytes, splenomegaly, evidence of extramedullary hematopoiesis, and bone marrow fibrosis,
36 enlarged spleen due to lymphoid hyperplasia, extramedullary hematopoiesis, and bone marrow hypoplasia
37 atopoietic stem and progenitor cell cycling, extramedullary hematopoiesis, and differentiation defect
38 gh incidence of premature death, age-related extramedullary hematopoiesis, and lack of early degenera
39 ymph nodes, splenomegaly due to erythrocytic extramedullary hematopoiesis, and lymphoid hyperplasia w
40 ave important implications for understanding extramedullary hematopoiesis, and may be relevant to cur
41 icrovesicular fatty metamorphosis, prolonged extramedullary hematopoiesis, and portal hypercellularit
42 poietic defects develop without compensatory extramedullary hematopoiesis, and the loss of HSCs occur
43 osis, resulting in extreme levels of splenic extramedullary hematopoiesis, anemia, and leukopenia.
44                      Dysmegakaryopoiesis and extramedullary hematopoiesis characterize primary myelof
45 gic malignancy characterized by BM fibrosis, extramedullary hematopoiesis, circulating CD34+ cells, s
46 rease in myeloid progenitor populations, and extramedullary hematopoiesis composed of maturing myeloi
47 e develop severe neutrophilia, splenomegaly, extramedullary hematopoiesis, decreased body weight, and
48 ient mice have a peripheral leukocytosis and extramedullary hematopoiesis, demonstrating that Lsc is
49 der steady-state conditions and mobilize for extramedullary hematopoiesis during periods of stress su
50 characterized by splenomegaly, leukocytosis, extramedullary hematopoiesis (EMH) in spleen and liver w
51                                              Extramedullary hematopoiesis (EMH) is induced during pre
52                                              Extramedullary hematopoiesis (EMH) refers to the differe
53               Ineffective erythropoiesis and extramedullary hematopoiesis (EMH) regress, as reflected
54 ere anemia (2-4 g/dL), massive splenomegaly, extramedullary hematopoiesis (EMH), and hepatic iron ove
55 aly, fibrotic and hypercellular bone marrow, extramedullary hematopoiesis in both spleen and liver, a
56  possibility of hemolytic anemia and splenic extramedullary hematopoiesis in Nrf2(-/-) mice.
57       We found that G6 significantly reduced extramedullary hematopoiesis in the liver and splenomega
58 mplicate IL-25-elicited MPP(type2) cells and extramedullary hematopoiesis in the promotion of Th2 cyt
59            Moreover, AEP deficiency provokes extramedullary hematopoiesis in the spleen and abnormall
60 erative phenotype, which was associated with extramedullary hematopoiesis in the spleen and liver, wa
61 lls; myeloid hyperplasia in bone marrow; and extramedullary hematopoiesis in the spleen and liver.
62 y high white blood cell counts and extensive extramedullary hematopoiesis in the spleen, liver, bone
63 tipotential progenitor cell mobilization and extramedullary hematopoiesis in the spleen.
64 one mass, reduced medullary cavity space and extramedullary hematopoiesis in the spleen.
65  marrow, and spleen; significantly increased extramedullary hematopoiesis in the spleen; and a 2-fold
66 sease phenotype-bone marrow stromal changes, extramedullary hematopoiesis, ineffective erythropoiesis
67 d circulating MIP-1alpha and ameliorated the extramedullary hematopoiesis, inflammation, and osteopen
68                                      Splenic extramedullary hematopoiesis is an integral component of
69 tipotential progenitor cell mobilization and extramedullary hematopoiesis, leading to decreased produ
70 oplasms (MPNs), including varying degrees of extramedullary hematopoiesis (myeloid metaplasia) and sp
71             In the orthotopic BALB/cJ model, extramedullary hematopoiesis occurred in the spleen, res
72            However, KRAS activation enhanced extramedullary hematopoiesis of MA4-expressing cell line
73 it, leukocytosis, megakaryocyte hyperplasia, extramedullary hematopoiesis resulting in splenomegaly,
74 , lead to autoinflammatory disease involving extramedullary hematopoiesis, skin and bone lesions.
75 by bone marrow fibrosis, myeloproliferation, extramedullary hematopoiesis, splenomegaly and leukemic
76 opoietic stem cell function, contributing to extramedullary hematopoiesis, splenomegaly, BM failure,
77                                              Extramedullary hematopoiesis was also evident, and granu
78                                    Increased extramedullary hematopoiesis was associated with elevate
79 ecrease in bone marrow hematopoiesis, active extramedullary hematopoiesis was observed in the spleen
80                Marked splenomegaly caused by extramedullary hematopoiesis was observed.
81 n the P-loop of Gimap5, lymphopenia, hepatic extramedullary hematopoiesis, weight loss, and intestina
82                Greater HSPC mobilization and extramedullary hematopoiesis were reversed by raising HD
83 -old IRP1(-/-) mice exhibit splenomegaly and extramedullary hematopoiesis, which is corrected in olde
84     Instead, these animals exhibit extensive extramedullary hematopoiesis with progressive splenomega

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。